285 related articles for article (PubMed ID: 7856283)
1. [Indications for ACE inhibitors in the postinfarct period].
Ertl G; Gaudron P; Neubauer S; Hu K; Zdrojewski T; Horn M; Kochsiek K
Z Kardiol; 1994; 83 Suppl 4():65-74. PubMed ID: 7856283
[TBL] [Abstract][Full Text] [Related]
2. [Angiotensin converting enzyme inhibitors during acute phase of myocardial infarct].
Mazzotta G; Vecchio C
G Ital Cardiol; 1994 Jan; 24(1):59-70. PubMed ID: 8200499
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin-converting enzyme inhibitors post-myocardial infarction.
Young JB
Cardiol Clin; 1995 Aug; 13(3):379-90. PubMed ID: 7585774
[TBL] [Abstract][Full Text] [Related]
4. [ACE inhibitors and angiotensin II receptor antagonists in acute coronary syndrome].
Milicić D
Acta Med Croatica; 2004; 58(2):129-34. PubMed ID: 15208798
[TBL] [Abstract][Full Text] [Related]
5. [Trials with ACE-inhibitors in acute myocardial infarction].
Dalla Volta S
Cardiologia; 1994 Dec; 39(12 Suppl 1):149-55. PubMed ID: 7634258
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
[TBL] [Abstract][Full Text] [Related]
7. [Converting enzyme inhibitors and coronary failure].
Castaigne A; Saal JP; Albo C; Verschuren P; Pham I
Rev Prat; 1992 Dec; 42(20):2568-73. PubMed ID: 1299942
[TBL] [Abstract][Full Text] [Related]
8. [New aspects of ACE inhibitor treatment of heart failure].
Dietz R; Osterziel KJ
Z Kardiol; 1996; 85 Suppl 6():241-6. PubMed ID: 9064971
[TBL] [Abstract][Full Text] [Related]
9. [Current aspects of ACE inhibitor therapy from the cardiologic viewpoint].
Klein W; Eber B; Gasser R; Stoschitzky K; Schumacher M; Fruhwald FM; Zweiker R
Wien Med Wochenschr; 1996; 146(11):221-4. PubMed ID: 8928518
[TBL] [Abstract][Full Text] [Related]
10. The Survival and Ventricular Enlargement (SAVE) study: rationale and perspective.
Pfeffer MA
Herz; 1993 Dec; 18 Suppl 1():430-5. PubMed ID: 8125423
[TBL] [Abstract][Full Text] [Related]
11. Ventricular remodeling and its prevention in the treatment of heart failure.
Patten RD; Udelson JE; Konstam MA
Curr Opin Cardiol; 1998 May; 13(3):162-7. PubMed ID: 9649938
[TBL] [Abstract][Full Text] [Related]
12. Therapy of left ventricular dysfunction: implications of recent therapeutic trials and future directions for therapy.
Pitt B
Schweiz Med Wochenschr; 1993 Feb; 123(8):342-8. PubMed ID: 8095738
[TBL] [Abstract][Full Text] [Related]
13. [Rationale, characteristics and study design of PREAMI (Perindopril and Remodelling in the Elderly with Acute Myocardial Infraction)].
Magrini G; Nicolosi GL; Chiariello M; Ferrari R; Remme P; Tavazzi L
Ital Heart J; 2005 Nov; 6 Suppl 7():14S-23S. PubMed ID: 16485513
[TBL] [Abstract][Full Text] [Related]
14. What have the ACE-inhibitor trials in postmyocardial patients with left ventricular dysfunction taught us?
Reynolds G; Hall AS; Ball SG
Eur J Clin Pharmacol; 1996; 49 Suppl 1():S35-9. PubMed ID: 8834930
[TBL] [Abstract][Full Text] [Related]
15. [ACE inhibitors in the treatment of patients after myocardial infarct].
Widimský J
Vnitr Lek; 1993 Jun; 39(6):527-35. PubMed ID: 8212605
[TBL] [Abstract][Full Text] [Related]
16. [ACE-inhibitors in acute heart infarct].
Genoni M; Garzoli G; Pfister M; Siegrist P; Malacrida R; Maggioni A; Moccetti T
Praxis (Bern 1994); 1996 Apr; 85(17):548-53. PubMed ID: 8668893
[TBL] [Abstract][Full Text] [Related]
17. [Angiotensin-converting enzyme inhibitors in patients with preserved left ventricular function: from EUROPA to PREAMI].
Ferrari R; Papa K; Bernocchi P; Gimbatti OJ; Golcea SS; Bettini A; Ceconi C
Ital Heart J; 2005 Nov; 6 Suppl 7():24S-32S. PubMed ID: 16485514
[TBL] [Abstract][Full Text] [Related]
18. [Prevention of postinfarction cardiac insufficiency: role of angiotensin converting enzyme inhibitors].
Guéret P; Cohen-Solal A; Bensaid J
Arch Mal Coeur Vaiss; 1992 Nov; 85(11 Suppl):1709-16. PubMed ID: 1304144
[TBL] [Abstract][Full Text] [Related]
19. [Treatment by angiotensin converting enzyme inhibitors after myocardial infarction. What did the clinical trials teach us?].
Guéret P; Garot J; Barnier P
Arch Mal Coeur Vaiss; 1996 Aug; 89 Spec No 3():33-8. PubMed ID: 8949316
[TBL] [Abstract][Full Text] [Related]
20. Reduction of ischemic events with angiotensin-converting enzyme inhibitors: lessons and controversy emerging from recent clinical trials.
Young JB
Cardiovasc Drugs Ther; 1995 Feb; 9(1):89-102. PubMed ID: 7786840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
